Proqr Therapeutics N V (PRQR)

06:37 AM

| MarketBeat - MarketBeat

06:37 AM

04:41 AM

ProQR Therapeutics (NASDAQ:PRQR) Upgraded at Citigroup - MarketBeat

04:41 AM

Mar 11, 2025

ProQR Therapeutics (NASDAQ:PRQR) Rating Increased to Buy at Citigroup - Defense World

Mar 11, 2025

Mar 10, 2025

ProQR Therapeutics upgraded by Citigroup with a new price target - Quantisnow

Mar 10, 2025

Mar 10, 2025

Citigroup Upgrades ProQR Therapeutics to Buy From Neutral, Price Target is $4 -March 10, 2025 at 07:33 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Citi raises ProQR stock rating to buy, sets $4 target By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Citi raises ProQR stock rating to buy, sets $4 target - Investing.com India

Mar 10, 2025

Mar 08, 2025

ProQR Therapeutics (PRQR) to Release Earnings on Wednesday - MarketBeat

Mar 08, 2025

Mar 08, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Cross Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Mar 08, 2025

Mar 05, 2025

ProQR Therapeutics (PRQR) Expected to Announce Earnings on Wednesday - Defense World

Mar 05, 2025

Mar 01, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Mar 01, 2025

Feb 25, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Feb 25, 2025

Feb 23, 2025

ProQR Therapeutics (NASDAQ:PRQR) Stock Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 23, 2025

Feb 17, 2025

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) market cap touched US$250m last week, benefiting both individual investors who own 59% as well as institutions - Simply Wall St

Feb 17, 2025

Feb 14, 2025

Analyzing ProQR Therapeutics (NASDAQ:PRQR) & Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World

Feb 14, 2025

Feb 13, 2025

Head to Head Contrast: ProQR Therapeutics (NASDAQ:PRQR) versus Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World

Feb 13, 2025

Feb 12, 2025

Jones Trading sets ProQR stock Buy rating, $11 price target - MSN

Feb 12, 2025

Feb 12, 2025

This Ralph Lauren Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Feb 12, 2025

Feb 12, 2025

Jones Trading Initiates Coverage of ProQR Therapeutics N.V. (PRQR) with Buy Recommendation - Nasdaq

Feb 12, 2025

Feb 11, 2025

Jones Trading sets ProQR stock Buy rating, $11 price target By Investing.com - Investing.com Australia

Feb 11, 2025

Feb 11, 2025

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) largest shareholders are individual investors with 60% ownership, institutions own 17% - Yahoo Finance

Feb 11, 2025

Feb 04, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Rating of "Buy" from Analysts - MarketBeat

Feb 04, 2025

Jan 31, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jan 31, 2025

Jan 27, 2025

Ballentine Partners LLC Takes Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jan 27, 2025

Jan 23, 2025

Analysts Offer Predictions for PRQR FY2025 Earnings - Defense World

Jan 23, 2025

Jan 22, 2025

Cantor Fitzgerald Weighs in on PRQR FY2025 Earnings - MarketBeat

Jan 22, 2025

Jan 14, 2025

ProQR Therapeutics (NASDAQ:PRQR) Short Interest Update - MarketBeat

Jan 14, 2025

Jan 13, 2025

ProQR Therapeutics' SWOT analysis: RNA editing firm's stock poised for growth - Investing.com

Jan 13, 2025

Jan 12, 2025

Oppenheimer Initiates Coverage on ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jan 12, 2025

Jan 09, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives $7.60 Consensus Target Price from Analysts - Defense World

Jan 09, 2025

Jan 06, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts - MarketBeat

Jan 06, 2025

Dec 19, 2024

BNP Paribas Financial Markets Increases Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Dec 19, 2024

Dec 17, 2024

ProQR Therapeutics' SWOT analysis: RNA-editing stock poised for clinical leap - Investing.com

Dec 17, 2024

Dec 15, 2024

ProQR Therapeutics’ (PRQR) “Market Outperform” Rating Reiterated at JMP Securities - Defense World

Dec 15, 2024

Dec 15, 2024

ProQR Therapeutics’ (PRQR) Buy Rating Reiterated at HC Wainwright - Defense World

Dec 15, 2024